February 13, 2026

With his symptoms easing due to cold weather, my brother seizes the day – Myasthenia Gravis News

February 12, 2026

New frontiers in myasthenia gravis therapy: FcRN inhibitors, complement inhibitors and anti-CD-19 therapy – Mayo Clinic Press

February 12, 2026

EUROPEAN COMMISSION APPROVES AMGEN’S UPLIZNA® FOR GENERALIZED MYASTHENIA GRAVIS – PR Newswire

February 12, 2026

UPLIZNA Approved in Europe for Myasthenia Gravis Treatment – Intellectia AI

February 12, 2026

European Commission Approves Uplizna as Add-On Therapy for Antibody-Positive Generalized Myasthenia Gravis – BioPharm International